ASTRAZENECA FDA Approval NDA 022172

NDA 022172

ASTRAZENECA

FDA Drug Application

Application #022172

Documents

Letter2007-11-19
Label2007-11-19
Other Important Information from FDA2007-12-03
Review2010-01-05
Summary Review2010-01-05

Application Sponsors

NDA 022172ASTRAZENECA

Marketing Status

Prescription001
Prescription002
Prescription003
Prescription004

Application Products

001TABLET, EXTENDED RELEASE; ORAL50MG0SEROQUEL XRQUETIAPINE FUMARATE
002TABLET, EXTENDED RELEASE; ORAL200MG0SEROQUEL XRQUETIAPINE FUMARATE
003TABLET, EXTENDED RELEASE; ORAL300MG0SEROQUEL XRQUETIAPINE FUMARATE
004TABLET, EXTENDED RELEASE; ORAL400MG0SEROQUEL XRQUETIAPINE FUMARATE

FDA Submissions

TYPE 6; Type 6 - New Indication (no longer used)ORIG1AP2007-11-15STANDARD

CDER Filings

ASTRAZENECA
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 22172
            [companyName] => ASTRAZENECA
            [docInserts] => ["",""]
            [products] => [{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"50MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"200MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"300MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"},{"drugName":"SEROQUEL XR","activeIngredients":"QUETIAPINE FUMARATE","strength":"400MG","dosageForm":"TABLET, EXTENDED RELEASE; ORAL","marketingStatus":"Prescription","te":"None","rld":"No","rs":"No"}]
            [labels] => [{"actionDate":"11\/15\/2007","submission":"ORIG-1","supplementCategories":"Approval","inserts":"[{\"name\":\"Label (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/label\\\/2007\\\/022172lbl.pdf\"}]","notes":""}]
            [originalApprovals] => [{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"50MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"200MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"300MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"SEROQUEL XR","submission":"QUETIAPINE FUMARATE","actionType":"400MG","submissionClassification":"TABLET, EXTENDED RELEASE; ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 2007-11-15
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.